Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
July 8, 2022
Human Infection Challenge with Serotype 3 Pneumococcus
Ryan E Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
The Journal of Clinical Investigation
|
February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2026
Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020
Ashley Tippett, Pragati V Prasad, Elizabeth Begier, et al.
American Heart Journal
|
May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design Update
Mats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
The Journal of Infectious Diseases
|
July 16, 2024
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
Dima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
Journal of the American College of Cardiology
|
August 30, 2025
Effect of RSV Vaccine on Heart Failure Hospitalizations: A Prespecified Analysis of the DAN-RSV Trial
Kristoffer Grundtvig Skaarup, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Heart Journal
|
August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial
Manan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Journal of Preventive Cardiology
|
June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial
Caroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
JAMA
|
August 30, 2025
Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial
Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
European Journal of Preventive Cardiology
|
April 30, 2026
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trial
Lisa Steen Duus, Mats C H Lassen, Niklas D Johansen, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
American Journal of Respiratory and Critical Care Medicine
|
July 8, 2022
Human Infection Challenge with Serotype 3 Pneumococcus
Ryan E Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
The Journal of Clinical Investigation
|
February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2026
Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020
Ashley Tippett, Pragati V Prasad, Elizabeth Begier, et al.
American Heart Journal
|
May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design Update
Mats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
The Journal of Infectious Diseases
|
July 16, 2024
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
Dima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
Journal of the American College of Cardiology
|
August 30, 2025
Effect of RSV Vaccine on Heart Failure Hospitalizations: A Prespecified Analysis of the DAN-RSV Trial
Kristoffer Grundtvig Skaarup, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Heart Journal
|
August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial
Manan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Journal of Preventive Cardiology
|
June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial
Caroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
JAMA
|
August 30, 2025
Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial
Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
European Journal of Preventive Cardiology
|
April 30, 2026
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trial
Lisa Steen Duus, Mats C H Lassen, Niklas D Johansen, et al.
Page
of 14